Consistency with Agreement. The Gilead Supplier shall be permitted to supply Lenacapavir and/or Product, or any raw materials or intermediates or components for primary and secondary packaging, including vial kit components, therefor, to Licensee only to the extent that any such supply does not (A) adversely affect its ability to meet ▇▇▇▇▇▇’s forecasted requirements or (B) adversely affect the Gilead Supplier’s ability to supply Gilead’s requirements, whether or not such requirements are consistent with Gilead’s twelve (12) month forecast. Gilead shall have the right to terminate any agreement between Licensee and its Gilead Suppliers if the supply of Lenacapavir and/or Product, or any raw materials or intermediates or components for primary and secondary packaging, including vial kit components, therefor, from such Gilead Supplier to Licensee adversely affects Gilead’s supply requirements as set forth in this Section 3.3(b).
Appears in 2 contracts
Sources: Lenacapavir License Agreement, Lenacapavir License Agreement